Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
Orthofix Medical Inc(OFIX)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for OFIX
11/06/2026: OFIX (1-star) is a SELL. SELL for 2 days. Simulated Profits (-12.89%). Updated daily EoD!
Orthofix Medical Inc is a specialized medical device company focused on spinal hardware and bone growth stimulation products. Following its 2023 merger with SeaSpine, the firm holds a stronger market presence in spine reconstruction. Its primary investment story hinges on successfully integrating these combined operations to drive scale and efficiency. Key risks include intense competition from larger medical device conglomerates and the execution challenges inherent in organizational restructuring. The stock is best suited for growth-oriented investors with a tolerance for volatility, as it currently lacks dividend income and faces competitive headwinds. Investors should monitor post-merger margin improvements and new product adoption rates.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Mixed fit | Potential upside exists from post-merger integration, but the company must demonstrate consistent execution. |
| Momentum investor | Mixed fit | Momentum depends on sustained positive sentiment regarding operational turnaround and revenue acceleration. |
| Value investor | Mixed fit | Valuation may be attractive relative to larger peers, but profitability metrics currently face integration headwinds. |
| Dividend investor | Weak fit | The company does not pay a dividend and focuses on reinvesting cash for growth. |
| Low-risk investor | Weak fit | High operational complexity and market competition lead to above-average price volatility. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | High | The stock often experiences significant swings due to earnings results and sector-wide sentiment. |
| Valuation risk | Medium | Investors must assess whether current pricing adequately accounts for the risks of integrating a large-scale merger. |
| Competition risk (Orthopedic/Spine) | High | Larger competitors with deeper pockets exert significant pressure on pricing and hospital access. |
| Business quality | Medium | The business is in a transition phase, and sustained franchise strength is being built following recent structural changes. |
| Dividend income | Low / none | There is no dividend income for investors to rely on, making capital appreciation the only path for returns. |
| Execution risk | High | Successful integration of recent acquisitions and sales channel management are critical to long-term performance. |
Price Behavior
Steep Decline
The stock price has dropped sharply with strong downward pressure.
Choppy
The stock has experienced frequent reversals and pronounced short-term price swings.
Analysis of Past Performance
Type Stock | Historic Profit -46.9% | Avg. Invested days 28 | Today’s Advisory SELL |
Upturn Advisory Rating  | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 11/06/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 318.12M USD | Price to earnings Ratio - | 1Y Target Price 13 |
Price to earnings Ratio - | 1Y Target Price 13 | ||
Volume (30-day avg) 477.5K shares | Beta 0.64 | 52 Weeks Range 7.81 - 16.42 | Updated Date 11/08/2026 |
52 Weeks Range 7.81 - 16.42 | Updated Date 11/08/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.52 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Global Spine | Cervical and lumbar fusion hardware, implants, and motion preservation products. | This is the core revenue driver focusing on surgical hardware solutions for spinal conditions. |
| Bone Growth Therapies | Pulsed electromagnetic field (PEMF) stimulators. | A specialized, high-margin niche that provides non-invasive healing solutions. |
| Orthopedics | External fixation and limb reconstruction systems. | Focuses on complex trauma and limb deformities, providing diversified exposure beyond the spine. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Valuation
Trailing PE - | Forward PE 500 | Enterprise Value 451.37M | Price to Sales(TTM) 0.38 |
Enterprise Value 451.37M | Price to Sales(TTM) 0.38 | ||
Enterprise Value to Revenue 0.54 | Enterprise Value to EBITDA 23.78 | Shares Outstanding 40.42M | Shares Floating 40.41M |
Shares Outstanding 40.42M | Shares Floating 40.41M | ||
Percent Insiders 2.17 | Percent Institutions 95.85 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.